Compass Pathways is rated a Hold due to high risk, funding needs, and the need for further data before reassessing the thesis ...
Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results